Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-07-22
2009-02-10
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S248000, C514S300000, C546S123000, C546S156000, C544S235000, C544S236000
Reexamination Certificate
active
07488739
ABSTRACT:
A platelet aggregation inhibitor comprising a quinolone derivative or a pharmaceutically acceptable salt thereof as an active ingredient, and a novel quinolone derivative or a pharmaceutically acceptable salt thereof useful as a platelet aggregation inhibitor.
REFERENCES:
patent: 3943141 (1976-03-01), Ellis et al.
patent: 4024255 (1977-05-01), Ellis et al.
patent: 5024998 (1991-06-01), Bodor
patent: 5106837 (1992-04-01), Carson et al.
patent: 5324718 (1994-06-01), Loftsson
patent: 5506214 (1996-04-01), Beutler
patent: 5648368 (1997-07-01), Egbertson et al.
patent: 5753666 (1998-05-01), Beasley et al.
patent: 5889009 (1999-03-01), Miyake et al.
patent: 6121287 (2000-09-01), Bjork et al.
patent: 6130231 (2000-10-01), Wityak et al.
patent: 6136823 (2000-10-01), Sakae et al.
patent: 6248739 (2001-06-01), Turner et al.
patent: 6358976 (2002-03-01), Wityak et al.
patent: 6458788 (2002-10-01), Vaillancourt et al.
patent: 6875869 (2005-04-01), Jansson
patent: 2002/0025961 (2002-02-01), Scarborough et al.
patent: 2002/0077486 (2002-06-01), Scarborough et al.
patent: 2002/0132806 (2002-09-01), Ruggeri et al.
patent: 2003/0060474 (2003-03-01), Bryant et al.
patent: 2003/0144305 (2003-07-01), Hardern et al.
patent: 2003/0153556 (2003-08-01), Levy et al.
patent: 2003/0162774 (2003-08-01), Scarborough et al.
patent: 2004/0147576 (2004-07-01), Scarborough et al.
patent: 2004/0186131 (2004-09-01), Wathen et al.
patent: 0 945 435 (1999-09-01), None
patent: 945435 (1999-09-01), None
patent: 1433774 (1976-04-01), None
patent: 2 372 986 (2002-09-01), None
patent: 50-29574 (1975-03-01), None
patent: 50-35191 (1975-04-01), None
patent: 2001-139555 (2001-05-01), None
patent: 2002-531567 (2002-09-01), None
patent: WO 97/04779 (1997-02-01), None
patent: WO 98/23592 (1998-06-01), None
patent: WO 99/32450 (1999-07-01), None
patent: WO 00/34283 (2000-06-01), None
patent: WO 00/40561 (2000-07-01), None
patent: WO 00/40563 (2000-07-01), None
patent: WO 01/25239 (2001-04-01), None
patent: WO 01/57037 (2001-08-01), None
patent: WO 02/06513 (2002-01-01), None
patent: WO 02/070487 (2002-09-01), None
patent: WO 02/092571 (2002-11-01), None
patent: WO 02/098856 (2002-12-01), None
patent: WO 03/022214 (2003-03-01), None
patent: WO 2004/019932 (2004-03-01), None
Losasso et al., J. Chemother. Oct. 1995, 7(5), 420-423.
Database Chemcats on STN—Accession No. 2003:2205826, Registry No. 375351-23-8 (2003), pp. 1.
Database Chemcats on STN—Accession No. 2002: 163154, Registry No. 375351-23-8 (2002), pp. 1.
International Search Report dated Oct. 26, 2004.
Nancee L. Oien, et al., “Broad-Spectrum Antiherpes Activities of 4-Hydroxyquinoline Carboxamides, a Novel Class of Herpesvirus Polymerase Inhibitors”, Antimicrobial Agents and Chemotherapy, 2002, 46(3):724-730.
Indian Office Action issued Feb. 13, 2008 in Patent Application No. 144/DELNP/2006.
Hirayama Fukushi
Kaga Daisuke
Koga Yuji
Moritani Yumiko
Moritomo Hiroyuki
Astellas Pharma Inc.
Dentz Bernard
Gallis David E
Sughrue & Mion, PLLC
LandOfFree
Quinolone derivative or salt thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolone derivative or salt thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolone derivative or salt thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107094